Therapeutic prostaglandin compounds used as ocular hypotensive agents

Details for Australian Patent Application No. 2009249386 (hide)

Owner Allergan, Inc.

Inventors Old, David W.; Ngo, Vinh X.

Agent Davies Collison Cave

Pub. Number AU-A-2009249386

PCT Pub. Number WO2009/142967

Priority 61/054,682 20.05.08 US

Filing date 13 May 2009

Wipo publication date 26 November 2009

International Classifications

C07C 405/00 (2006.01) Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins

A61K 31/192 (2006.01)

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4439 (2006.01)

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07C 225/22 (2006.01) Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a CHO group, e.g. amino ketones

C07C 323/22 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07D 213/70 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 295/088 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/68 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/38 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/142967 Priority application(s): WO2009/142967

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009249388-Therapeutic lactams

2009249382-System and method for locating WiMAX or LTE subscriber stations